Allena Pharmaceuticals (@allenapharma) 's Twitter Profile
Allena Pharmaceuticals

@allenapharma

Biopharma company developing 1st-in-class therapies for rare & severe metabolic disorders impacting the kidney. See community guidelines bit.ly/2PKgF8S

ID: 1009080529617145856

linkhttps://www.allenapharma.com/ calendar_today19-06-2018 14:28:40

237 Tweet

455 Followers

46 Following

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

Hyperuricemia is associated with an excess of urate in the blood, which can lead to #kidneystones and the formation of needlelike crystals in the joints. Learn more about #hyperuricemia here: bit.ly/3uxp1qf

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

In September, the National Kidney Foundation and American Society of Nephrology Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases released a report outlining a new method to diagnose #kidneydisease and advance #healthequity. Learn more: bit.ly/3ou5x4L

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

In enteric #hyperoxaluria, the absorption of too much oxalate from foods due to an underlying malabsorptive gastrointestinal condition can lead to the formation of #kidneystones and other complications. Learn more: bit.ly/3B4bSax

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

We are proud to join Oxalosis & Hyperoxaluria Foundation in recognizing #HyperoxaluriaWeek2021! Community activities throughout the week will put a spotlight on challenges in #hyperoxaluria and the importance of early diagnosis. Learn how to participate here: bit.ly/2Ygh793 #RaiseTheHype2021

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

We recently announced Allena received Fast Track designation from the U.S. FDA for a treatment of hyperuricemia in gout patients with advanced chronic kidney disease. For details, see our press release: bit.ly/2ZRQS96 #KidneyWk #kidneydisease #CKD

We recently announced Allena received Fast Track designation from the U.S. FDA for a treatment of hyperuricemia in gout patients with advanced chronic kidney disease. For details, see our press release: bit.ly/2ZRQS96 #KidneyWk #kidneydisease #CKD
Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

In this interview with Urology Times, expert endourologist Dr. Kyle Wood of UAB describes the diagnostic processes of enteric hyperoxaluria, as well as common challenges faced in reaching a diagnosis: bit.ly/38zz443 #HyperoxaluriaWeek2021 #RaiseTheHype2021 Oxalosis & Hyperoxaluria Foundation

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

This #HyperoxaluriaWeek2021, Oxalosis & Hyperoxaluria Foundation is providing members of the #hyperoxaluria community a special opportunity to share their diagnosis stories. Learn more: bit.ly/3weONAv #RaiseTheHype2021

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

In enteric #hyperoxaluria, an underlying malabsorptive GI condition leads to absorption of too much oxalate from foods. Too much oxalate in the urine may cause inflammation or #kidneystones. Learn more: bit.ly/3uxp1qf #HyperoxaluriaWeek2021 #RaiseTheHype2021 Oxalosis & Hyperoxaluria Foundation

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

Stories from the #hyperoxaluria community continue to inspire our team at Allena. Watch Oxalosis & Hyperoxaluria Foundation’s Faces of Hyperoxaluria video to hear stories from individuals and families affected by hyperoxaluria: bit.ly/3nU7DsV #HyperoxaluriaWeek2021 #RaiseTheHype2021

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

Although #HyperoxaluriaWeek2021 has come to an end, there is still work to be done to ensure all members of the #hyperoxaluria community receive the support they need. Thank you to Oxalosis & Hyperoxaluria Foundation for creating a platform to bring hope to patients and families. bit.ly/2Ygh793

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

The most common type of kidney stones are calcium stones, which are caused by a substance called calcium oxalate. For some people, these types of stones are the result of a condition called enteric #hyperoxaluria. Learn more about enteric hyperoxaluria: bit.ly/3B4bSax

The most common type of kidney stones are calcium stones, which are caused by a substance called calcium oxalate. For some people, these types of stones are the result of a condition called enteric #hyperoxaluria. Learn more about enteric hyperoxaluria: bit.ly/3B4bSax
Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

#ICYMI In November, our leadership team presented a corporate overview at the Stifel 2021 Virtual Healthcare Conference. Access a webcast recording of the presentation here: bit.ly/3y3uPts

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

In this video, expert endourologist Dr. Kyle Wood of UAB reviews data and clinical implications from the Phase 3 URIROX trial in enteric #hyperoxaluria: bit.ly/31E2f5t

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

During American Society of Nephrology’s Annual Meeting & Scientific Exposition, National Kidney Foundation presented the NKF Patient Network, a program created to help people living with #kidneydisease access important updates on clinical research. Learn more: bit.ly/3do4nBd

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

Hyperuricemia is associated with an excess of urate in the blood, which can lead to #kidneystones and the formation of needlelike crystals in the joints. Learn more about #hyperuricemia here: bit.ly/3uxp1qf

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

In enteric #hyperoxaluria, the absorption of too much oxalate from foods due to an underlying malabsorptive gastrointestinal condition can lead to the formation of #kidneystones and other complications. Learn more: bit.ly/3B4bSax

LifeSci Advisors (@lifesciadvisors) 's Twitter Profile Photo

Please join us for Allena Pharmaceuticals KOL Event to Review Topline ALLN- 346 Phase 2a Data featuring Key Opinion Leaders Robert Terkeltaub, M.D. (UC San Diego) and David S. Goldfarb, M.D. (NYU Langone). A live Q&A session will follow. Register here: lifesci.events/ALNA2

Please join us for <a href="/AllenaPharma/">Allena Pharmaceuticals</a> KOL Event to Review Topline ALLN- 346 Phase 2a Data featuring Key Opinion Leaders Robert Terkeltaub, M.D. (UC San Diego) and David S. Goldfarb, M.D. (NYU Langone). A live Q&amp;A session will follow. Register here: lifesci.events/ALNA2
Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

Today we shared progress updates on our clinical development programs in #hyperuricemia and #gout in the setting of chronic kidney disease as well as enteric #hyperoxaluria, and a corporate update. For details, see our press release: ir.allenapharma.com/news-releases/…

Allena Pharmaceuticals (@allenapharma) 's Twitter Profile Photo

Today we shared progress updates on our clinical development program in #hyperuricemia and #gout in the setting of chronic kidney disease ir.allenapharma.com/news-releases/…